Antipsychotic Drug Use in Nursing Homes – CMS Trend Update

Published: 07/26/2019

  • Centers for Medicare and Medicaid Services
Relevant To:
  • Long Term Care

The U.S. Centers for Medicare and Medicaid Services (CMS) is tracking the progress of the National Partnership to Improve Dementia Care in Nursing Homes by reviewing publicly reported measures. The official measure of the Partnership is the percentage of long-stay nursing home residents who receive antipsychotic medication, excluding residents diagnosed with schizophrenia, Huntington's disease, or Tourette’s syndrome.

In the fourth quarter of 2011, 23.9 percent of long-stay nursing home resid

Sign Up for Free Trial